C
TARS icon

Covestor’s Tarsus Pharmaceuticals TARS Stock Holding History

Covestor’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$49K Buy
782
+3
+0.4% +$192 0.03% 795
2026
Q1 		$55K Buy
779
+754
+3,016% +$52.7K 0.04% 654
2025
Q4 		$2K Sell
25
-22
-47% -$1.64K ﹤0.01% 1958
2025
Q3 		$3K Buy
47
+9
+24% +$443 ﹤0.01% 1898
2025
Q2 		$2K Sell
38
-3
-7% -$135 ﹤0.01% 1897
2025
Q1 		$2K Buy
41
+38
+1,267% +$1.88K ﹤0.01% 1888
2024
Q4 		$0 Hold
3
– – ﹤0.01% 2726
2024
Q3 		$0 Hold
3
– – ﹤0.01% 2750
2024
Q2 		$0 Hold
3
– – ﹤0.01% 2738
2024
Q1 		$0 Buy
+3
New +$88 ﹤0.01% 2721

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Covestor's TARS Position: Q2 2026 in Review

Covestor increased its Tarsus Pharmaceuticals (TARS) stake by 0.39% in Q2 2026, buying an estimated $192 and bringing the position to 782 shares worth $49K. The position accounts for 0.03% of the portfolio, ranked #795.

Covestor first reported a position in TARS in Q1 2024 and has held it in 10 quarters since. The position peaked at $55K in Q1 2026. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Covestor held 782 shares of Tarsus Pharmaceuticals worth $49K as of Q2 2026.
  • Covestor bought 3 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $192.
  • Tarsus Pharmaceuticals made up 0.03% of Covestor's portfolio in Q2 2026, its #795 holding.
  • Covestor first reported a position in Tarsus Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
  • Covestor's Tarsus Pharmaceuticals position peaked at $55K in Q1 2026.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.